Cargando…

Risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children

BACKGROUND: After primary mitral valve (MV) repair, residual mitral valve regurgitation (MR) and recurred mitral valve stenosis (MS) are the principal occurrences. This study’s purpose is to identify the risk factors of MV dysfunction, reoperation and death following repair of primary MV diseases. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yixuan, Jiang, Na, Chen, Gang, Mi, Yaping, Zhong, Hui, Jia, Bing, Zhang, Huifeng, Ye, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482615/
https://www.ncbi.nlm.nih.gov/pubmed/37691651
http://dx.doi.org/10.21037/jtd-23-270
_version_ 1785102209816461312
author Cai, Yixuan
Jiang, Na
Chen, Gang
Mi, Yaping
Zhong, Hui
Jia, Bing
Zhang, Huifeng
Ye, Ming
author_facet Cai, Yixuan
Jiang, Na
Chen, Gang
Mi, Yaping
Zhong, Hui
Jia, Bing
Zhang, Huifeng
Ye, Ming
author_sort Cai, Yixuan
collection PubMed
description BACKGROUND: After primary mitral valve (MV) repair, residual mitral valve regurgitation (MR) and recurred mitral valve stenosis (MS) are the principal occurrences. This study’s purpose is to identify the risk factors of MV dysfunction, reoperation and death following repair of primary MV diseases. METHODS: We retrospectively reviewed 98 patients (47 males and 51 females) with primary MV diseases between January 2013 and December 2021. The median age was 34 months [interquartile range (IQR), 11.4–59] for male and 24 months (IQR, 7.35–72) for female. The left ventricular ejection fraction (LVEF), the left ventricular end-diastolic volume index (LVEDVI) and left ventricular end-systolic volume index (LVESVI) were assessed to evaluate patient’s left ventricular function. Risk factors that increased the likelihood of MV dysfunction, reoperation and death after surgery were investigated. RESULTS: During the 23.5 months (IQR, 9–44.5) of follow-up, 5 (5.1%) patients died, including one early death and two late deaths (n=3; 3.9%) in the MR group and one early death and one late death (n=2; 9.1%) in the MS group. Seven (9.2%) patients in the primary MR disease group and 2 (9.1%) patients in the primary MS disease group required a second MV operation for a total reoperation rate of 9.2% (9/98). As of the most recent follow-up, 34 patients experienced MV dysfunction. No significant difference was recorded between primary MR and MS disease groups in Kaplan-Meier freedom from MV dysfunction and reoperation. Mixed MV pathology (P=0.014) acted as an independent risk factor for MV dysfunction, and ≥ moderate MR at 24 h after first surgery (P=0.014) an independent risk factor for MV reoperation. Double-orifice MV technique (P=0.002), MV reoperation (P=0.023) and severe MR at 24 h after first surgery (P=0.028) were independent risk factors for death. CONCLUSIONS: The Kaplan-Meier freedom from MV dysfunction and reoperation were comparable between primary MR and MS disease groups. A high probability of MV dysfunction was predicted due to the mixed MV pathology. Patients with ≥ moderate MR at 24 h after first surgery had a higher risk of MV reoperation. Double-orifice MV technique, MV reoperation and severe MR at 24 h after first surgery had a higher risk for death.
format Online
Article
Text
id pubmed-10482615
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104826152023-09-08 Risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children Cai, Yixuan Jiang, Na Chen, Gang Mi, Yaping Zhong, Hui Jia, Bing Zhang, Huifeng Ye, Ming J Thorac Dis Original Article BACKGROUND: After primary mitral valve (MV) repair, residual mitral valve regurgitation (MR) and recurred mitral valve stenosis (MS) are the principal occurrences. This study’s purpose is to identify the risk factors of MV dysfunction, reoperation and death following repair of primary MV diseases. METHODS: We retrospectively reviewed 98 patients (47 males and 51 females) with primary MV diseases between January 2013 and December 2021. The median age was 34 months [interquartile range (IQR), 11.4–59] for male and 24 months (IQR, 7.35–72) for female. The left ventricular ejection fraction (LVEF), the left ventricular end-diastolic volume index (LVEDVI) and left ventricular end-systolic volume index (LVESVI) were assessed to evaluate patient’s left ventricular function. Risk factors that increased the likelihood of MV dysfunction, reoperation and death after surgery were investigated. RESULTS: During the 23.5 months (IQR, 9–44.5) of follow-up, 5 (5.1%) patients died, including one early death and two late deaths (n=3; 3.9%) in the MR group and one early death and one late death (n=2; 9.1%) in the MS group. Seven (9.2%) patients in the primary MR disease group and 2 (9.1%) patients in the primary MS disease group required a second MV operation for a total reoperation rate of 9.2% (9/98). As of the most recent follow-up, 34 patients experienced MV dysfunction. No significant difference was recorded between primary MR and MS disease groups in Kaplan-Meier freedom from MV dysfunction and reoperation. Mixed MV pathology (P=0.014) acted as an independent risk factor for MV dysfunction, and ≥ moderate MR at 24 h after first surgery (P=0.014) an independent risk factor for MV reoperation. Double-orifice MV technique (P=0.002), MV reoperation (P=0.023) and severe MR at 24 h after first surgery (P=0.028) were independent risk factors for death. CONCLUSIONS: The Kaplan-Meier freedom from MV dysfunction and reoperation were comparable between primary MR and MS disease groups. A high probability of MV dysfunction was predicted due to the mixed MV pathology. Patients with ≥ moderate MR at 24 h after first surgery had a higher risk of MV reoperation. Double-orifice MV technique, MV reoperation and severe MR at 24 h after first surgery had a higher risk for death. AME Publishing Company 2023-08-01 2023-08-31 /pmc/articles/PMC10482615/ /pubmed/37691651 http://dx.doi.org/10.21037/jtd-23-270 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Cai, Yixuan
Jiang, Na
Chen, Gang
Mi, Yaping
Zhong, Hui
Jia, Bing
Zhang, Huifeng
Ye, Ming
Risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children
title Risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children
title_full Risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children
title_fullStr Risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children
title_full_unstemmed Risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children
title_short Risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children
title_sort risk factors for mitral valve dysfunction, reoperation and death following repair of the primary mitral valve disease in children
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482615/
https://www.ncbi.nlm.nih.gov/pubmed/37691651
http://dx.doi.org/10.21037/jtd-23-270
work_keys_str_mv AT caiyixuan riskfactorsformitralvalvedysfunctionreoperationanddeathfollowingrepairoftheprimarymitralvalvediseaseinchildren
AT jiangna riskfactorsformitralvalvedysfunctionreoperationanddeathfollowingrepairoftheprimarymitralvalvediseaseinchildren
AT chengang riskfactorsformitralvalvedysfunctionreoperationanddeathfollowingrepairoftheprimarymitralvalvediseaseinchildren
AT miyaping riskfactorsformitralvalvedysfunctionreoperationanddeathfollowingrepairoftheprimarymitralvalvediseaseinchildren
AT zhonghui riskfactorsformitralvalvedysfunctionreoperationanddeathfollowingrepairoftheprimarymitralvalvediseaseinchildren
AT jiabing riskfactorsformitralvalvedysfunctionreoperationanddeathfollowingrepairoftheprimarymitralvalvediseaseinchildren
AT zhanghuifeng riskfactorsformitralvalvedysfunctionreoperationanddeathfollowingrepairoftheprimarymitralvalvediseaseinchildren
AT yeming riskfactorsformitralvalvedysfunctionreoperationanddeathfollowingrepairoftheprimarymitralvalvediseaseinchildren